NEO
#2044
NeoGenomics, Inc. - Common Stock
14.2 4 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.92%
Monthly Change
+26.13%
6 month change
+7.96%
Year Change
+97.23%
Previous Close
14.1 1
Open
14.1 7
Low
14.1 1
High
14.2 8
Volume
1 151
Financials
- Market Capitalization 1.85 B
- Employee 2 500
- Founded 2002
- CEO Christopher M. Smith
- Website www.neogenomics.com
- Headquarter Nevada, United States
- FIGI BBG000BKH263
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-13.95
Price to sales ratio
2.07
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1674 |  GRAL GRAIL, Inc. - Common Stock | 73.00 USD | +1.67% | +6.12% | +15.87% | -26.26% | 3.13 B USD | ||
| 1957 |  NEOG Neogen Corporation - Common Stock | 9.68 USD | +0.31% | +3.09% | +4.99% | +81.95% | 2.11 B USD | ||
| 2154 |  PSNL Personalis, Inc. - Common Stock | 15.03 USD | -0.07% | +7.51% | +50.60% | +129.82% | 1.57 B USD | ||
| 2191 |  CDNA CareDx, Inc. - Common Stock | 28.93 USD | +0.59% | +2.19% | +25.67% | +94.03% | 1.49 B USD |
Frequently asked questions about NeoGenomics, Inc. - Common Stock
What is the NeoGenomics, Inc. - Common Stock stock price today?
The current price of NeoGenomics, Inc. - Common Stock (NEO) is 14.24. Over the past 24 hours, the stock has changed by +0.92%. Follow the NEO chart for real-time price dynamics.
What is the stock ticker of NeoGenomics, Inc. - Common Stock?
NeoGenomics, Inc. - Common Stock trades under the ticker NEO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NeoGenomics, Inc. - Common Stock stock going up?
NEO has changed by -1.79% over the last week, +26.13% over the last month, and +97.23% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was NeoGenomics, Inc. - Common Stock net income for the last quarter?
NeoGenomics, Inc. - Common Stock reported net income of -17.11 M for the last quarter. The previous quarter showed -9.88 M, which means net income changed by -73.12%.
How many employees does NeoGenomics, Inc. - Common Stock have?
As of the latest available data, NeoGenomics, Inc. - Common Stock has 2 500 employees. Workforce size can provide additional context about the company's scale and operations.
What is NeoGenomics, Inc. - Common Stock EBITDA?
NeoGenomics, Inc. - Common Stock EBITDA is -1.83 M, and its EBITDA margin is -0.98%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NeoGenomics, Inc. - Common Stock stock?
You can buy NeoGenomics, Inc. - Common Stock (NEO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NeoGenomics, Inc. - Common Stock stock?
Investing in NeoGenomics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEO chart and related analysis on metatrader.com as part of your research.